Management of neuropathic pain following treatment for breast cancer in the absence of recurrence: A challenge for the radiation oncologist

Australasian Radiology

Volumn 48, Issue 4, 2004, Pages 459-465

  Clubb, Bryce ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Breast cancer; Neuropathic pain; Radiation therapy

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; BRETYLIUM; CARBAMAZEPINE; CLONAZEPAM; CLONIDINE; FELBAMATE; GABAPENTIN; GUANETHIDINE; KETAMINE; KETANSERIN; LAMOTRIGINE; LIDOCAINE; MEXILETINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PHENYTOIN; RESERPINE; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

AGRANULOCYTOSIS; ANALGESIA; ANALGESIC ACTIVITY; APLASTIC ANEMIA; ATAXIA; BEHAVIOR THERAPY; BLOOD TOXICITY; BREAST CANCER; CANCER RECURRENCE; CARDIOTOXICITY; CEREBELLUM ATROPHY; CLINICAL TRIAL; COGNITIVE THERAPY; CONSCIOUSNESS DISORDER; CONSTIPATION; DIARRHEA; DIPLOPIA; DIZZINESS; DORSAL ROOT; DORSAL ROOT ENTRY ZONE LESIONING; DREAM LIKE STATE; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; FATIGUE; GINGIVA HYPERPLASIA; HEADACHE; HIRSUTISM; HUMAN; HYPERTENSION; LIVER FAILURE; LOUDNESS RECRUITMENT; MICTURITION DISORDER; MOOD DISORDER; NAUSEA; NEPHROLITHIASIS; NEUROPATHIC PAIN; NIGHTMARE; NONHUMAN; NYSTAGMUS; OPTIMAL DRUG DOSE; ORTHOSTATIC HYPOTENSION; PERIPHERAL NEUROPATHY; PHYSIOTHERAPY; PRIORITY JOURNAL; RADIATION ONCOLOGIST; RADIOLOGIST; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SPINAL ANESTHESIA; STEVENS JOHNSON SYNDROME; SYMPATHECTOMY; TACHYCARDIA; VISUAL IMPAIRMENT; VOMITING; WITHDRAWAL SYNDROME; XEROSTOMIA;

ANALGESICS, OPIOID; ANESTHETICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BREAST NEOPLASMS; FEMALE; HUMANS; NERVE BLOCK; NERVOUS SYSTEM DISEASES; PAIN; SYMPATHOLYTICS;

EID: 11144278231     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2004.01346.x     Document Type: Review

References (67)

1. Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 1995; 6: 453-9.
2. Kwekkebomm K. Postmastectomy pain syndromes. Cancer Nurs 1996; 19: 37-43.
3. Stevens PE, Dibble SL, Miaskowski C. Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women's experiences. Pain 1995; 61: 61-8.
4. Rosso R, Scelsi M, Carnevali L. Granular cell traumatic neuroma: a lesion occurring in mastectomy scars. Arch Pathol Lab Med 2000; 124: 709-11.
5. Wallace AM, Wallace MS. Postmastectomy and postthoracotomy pain. Anaesth Clin North Am 1997; 15: 353-70.
6. Kalso E, Tuna T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1995; 64: 293-302.
7. Watson CPN, Vernich M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998; 51: 1116-71.
8. Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Europ J Pain 2002; 6: 17-24.
9. Sindrup SH, Gram LF, Skjold J, Froland A, Beck-Nielsen H. Clin Pharmacol Ther 1990; 74: 509-15.
10. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic nonmalignant pain: a met-analysis of 39 placebo-controlled studies. Pain 1992; 49: 205-19.
11. Max MB, Culnane M, Schafer SC. Amitriptyline relieves neuropathic pain in patients with normal or depressed mood. Neurology 1987; 37: 589-96.
12. McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993; 48: 281-5.
13. Max MB, Lynch SA, Muir J. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-6.
14. Glassman AH. Cardiovascular effects of tricyclic antidepressants. Annu Rev Med 1984; 35: 503-11.
15. Backonja M, Beydoun A, Edwards K et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998; 280: 1831-6.
16. Rowbotham M, Harden N, Stacey B, Bernstein P, Margnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998; 280: 1837-42.
17. Chang VT. Intravenous phenytoin in the management of crescendo pelvic cancer-related pain. J Pain Symptom Manage 1997; 13: 238-40.
18. Burchiel KJ. Carbamazepine inhibits spontaneous activity in experimental neuromas. Exp Neuro 1998; 102: 249-51.
19. Laech MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: 2 neurochemical studies on the mechanism of action. Epilepsia 1986; 27: 490-7.
20. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanisms of action. Epilepsia 2000; 41 (Suppl. 1): S3.
21. Smith GM, Lowenstein E, Hubbard JH, Beecher HK. Experimental pain produced by the submaximum effort torniquet technique: further evidence of validity. J Pharmacol Exp Ther 1968; 163: 468-74.
22. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989; 37: 111-23.
23. Lamotte C, Pert CB, Snyder SH. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res 1976; 112: 407-12.
24. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-41.
25. Raja SN, Haythornthwaite JA, Paggagallo M et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59: 1015-21.
26. Portenoy RK. The pharmacological management of cancer pain. J Psychosoc Oncol 1990; 8: 75-107.
27. Sindrup SH, Anderson G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain 1999; 83: 85-90.
28. Kalso E, Allan L, Dellemijn PL et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7: 381-6.
29. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharges without blocking nerve conduction. Pain 1992; 48: 261-8.
30. Chabal C, Russell LC, Burchial KJ. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneous active fibres originating in rat sciatic neuromas. Pain 1989; 38: 33-8.
31. Mao J, Chen LC. Systemic lidocaine for neuropathic pain relief. Pain 2000; 87: 7-17.
32. Galer BS, Miller KV, Rowbotham MC. Responses to intravenous lidocaine infusion differ based on clinical diagnosis and site of nervous system injury. Neurology 1993; 43: 1233-5.
33. Attal N, Brasseur L, Chauvin M, Bouhassira D. Effects of single and multiple applications of eutectic mixture of local anaesthetics (EMLA) cream on spontaneous and evoked pain in post-herpetic neuralgia. Pain 1999; 81: 203-9.
34. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65: 39-44.
35. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53: 27-30.
36. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary approach. Pain 1994; 56: 51-7.
37. Walker SM, Cousins MJ. Reduction in hyperalgesia and intrathecal morphine requirements by low-dose ketamine infusion. J Pain Symptom Manage 1997; 14: 129-33.
38. Wang JK, Johnson KA, Ilstrup DM. Sympathetic blocks for reflex sympathetic dystrophy. Pain 1985; 23: 13-17.
39. Kozin F. Reflex sympathetic dystrophy syndrome: a review. Clin Exper Rheum 1992; 10: 401-9.
40. Ramamurthy S, Hoffman J, Group GS. Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Anest Analg 1995; 81: 718-23.
41. Blanchard J, Ramamurthy S, Walsh N, Hoffman J, Schoenfield L. intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine and normal saline. J Pain Symptom Manage 1990; 5: 357-61.
42. Hord AH, Rooks MD, Stephens BO, Rogers HG, Fleming LL. Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy; a randomized double-blind crossover study. Anesth Analg 1992; 74: 818-21.
43. Hanna MH, Peat SJ. Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial. Pain 1989; 38: 145-50.
44. Glynn CJ, Stannard C, Collinns PA, Casale R. The role of peripheral sudomotor blockade in the treatment of patients with sympathetically maintained pain. Pain 1993; 53: 39-42.
45. Kettler RE, Abram SE. Intravenous regional droperidol in the management of reflex sympathetic dystrophy: a double-blind, placebo-controlled, crossover study. Anaesthesiology 1988; 69: 933-6.
46. Verdugo R, Ochoa JL. Sympathetically maintained pain. I. Phentolamine block questions to concept. Neurology 1994; 44: 1003-10.
47. Galer BS. Peak relief is delayed and duration of relief is extended following intravenous phentolamine infusion. Preliminary report. Reg Anaesth 1995; 20: 444-7.
48. Jones SL, Gebhart GF. Characterization of coeruleospinal inhibition of the nociceptic tail-flick in the rat: mediation by spinal alpha 2-adrenoreceptors. Brain Res 1986; 364: 315-30.
49. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22: 845-58.
50. Reddy SVR, Yaksh TL. Spinal noradrenergic terminal system mediates antinociception. Brain Res 1980; 189: 391-401.
51. Davis KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991; 47: 309-17.
52. Byas-Smith MG, Max MB, Muir J, Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain 1995; 60: 267-74.
53. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side-effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmaco ther 1988; 43: 363-71.
54. Cohen KL, Harris S. Efficacy and safety of non-steroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987; 147: 1442-4.
55. Weber H, Holme I, Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine 1993; 11: 1433-8.
56. Christensen K, Jensen EM, Noer I. The reflex sympathetic syndrome response to treatment with systemic steroids. Acta Chir Scand 1982; 148: 653-5.
57. Cui JG, O'Connor WI, Ungerstedt U. Spinal cord stimulation attenuates dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism. Pain 1977; 73: 87-95.
58. Petrakis IE, Sciacca V. Spinal cord stimulation in diabetic lower limb critical ischaemia: transcutaneous oxygen measurement as predictor of success. Eur J Vasc Endovasc Surg 2000; 19: 587-92.
59. Hassenbusch SJ, Stanton-Hicks M, Covington EC. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10: 527-43.
60. Eisenach JC, DuPen S, Dubois M. Epidural clonidine analgesia for intractable cancer pain. Pain 1995; 61: 391-9.
61. Zeidman SM, Rossitch EJ, Nashold BS. Dorsal root entry zone lesioning in the treatment of pain related to radiation-induced brachial plexopathy. J Spinal Disorders 1993; 6: 44-7.
62. Jnesen MP, Turner JA, Romano JM. Chronic pain coping measures: individual vs composite scores. Pain 1992; 51: 273-80.
63. Jensen MP, Turner JA, Romano JM. Coping with chronic pain: a critical review of the literature. Pain 1991; 47: 249-83.
64. Turk DC, Rudy TE. Assessment of cognitive factors in chronic pain. A worthwhile enterprise? J Consult Clin Psychol 1986; 54: 760-8.
65. McCracken LM, Turk DC. Behavioral and cognitive-behavioral treatment for chronic pain. Spine 2002; 27: 2564-73.
66. Bonica JJ. Multidisciplinary/Interdisciplinary pain programs. In: Bonica JJ (ed.). The Management of Pain, 2nd edn, vol. 1. Lea & Febiger, Philadelphia, PA, 1990; 197-208.
67. Lee MHM, Itoh M, Yang G-FW, Eason AL. Physical therapy and rehabilitation medicine. In: Bonica JJ (ed.). The Management of Pain, 2nd edn, vol. 1. Lea & Febiger, Philadelphia, PA, 1990; 1769-85.